RFK Jr. seeks to soften CDC vaccine recommendations, shifting flu & meningococcal vaccines to shared decision-making; CDC now ...
Ambros Therapeutics will take the Nasdaq spot of Werewolf Therapeutics, a cancer biotech that has been exploring strategic ...
Genentech builds $750M OR facility; Bavarian Nordic delays Lyme vaccine to 2028; Xspray gets 2nd CRL for Dasynoc over ...
Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer.
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
FDA rejects Osteal Therapeutics' Nexchange Kit antibiotic combo for joint-implant infections, citing trial-design flaws and ...
People who buy gray-market retatrutide aren't experiencing the same amount of weight loss as actual trial participants.
FDA's TEMPO pilot added Limbic, Cadence & Dexcom, letting digital health firms skip premarket authorization in exchange for ...
Lilly partners with Amplitude on taRNA vaccines; Otsuka axes an early psychedelic trial from its Mindset buy. Plus: AC Immune's NLRP3 data, Adverum layoffs, and SiranBio's $59M Series A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results